We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$19.9B
AUM Growth
+$1.62B
Cap. Flow
-$35.6M
Cap. Flow %
-0.18%
Top 10 Hldgs %
43.73%
Holding
208
New
17
Increased
41
Reduced
35
Closed
35

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$384M
2
VMW
VMware, Inc
VMW
+$286M
3
UNH icon
UnitedHealth
UNH
+$192M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$158M
5
IQV icon
IQVIA
IQV
+$132M

Top Sells

Rank Stock Value
1
SJR
Shaw Communications Inc.
SJR
+$473M
2
DT icon
Dynatrace
DT
+$329M
3
CRM icon
Salesforce
CRM
+$318M
4
MSFT icon
Microsoft
MSFT
+$253M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$191M

Sector Composition

Rank Sector Weight
1 Healthcare 35.32%
2 Technology 16.45%
3 Financials 12.17%
4 Industrials 7.23%
5 Communication Services 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVCP
101
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$3.1M 0.02%
300,000
-1,680,000
-85% -$17.4M
BACA
102
DELISTED
Berenson Acquisition Corp. I
BACA
$2.93M 0.01%
285,715
-2,189,285
-88% -$22.3M
ATTO
103
DELISTED
Atento S.A.
ATTO
$2.23M 0.01%
2,230,357
– –
ARYD
104
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.13M 0.01%
200,000
– –
PRVA icon
105
Privia Health
PRVA
$2.7B
$1.93M 0.01%
+74,000
New +$1.95M
GATE
106
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.56M 0.01%
150,000
– –
ICE icon
107
Intercontinental Exchange
ICE
$90.5B
$1.45M 0.01%
12,786
-39,046
-75% -$4.23M
BPMC
108
DELISTED
Blueprint Medicines
BPMC
$1.42M 0.01%
22,420
– –
MTAL.WS
109
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$1.16M 0.01%
825,000
– –
OKLO
110
Oklo
OKLO
$7.83B
$1.03M 0.01%
98,300
– –
SMC
111
Summit Midstream
SMC
$470M
$946K ﹤0.01%
58,214
– –
TECX
112
Tectonic Therapeutic
TECX
$736M
$855K ﹤0.01%
74,975
-184,692
-71% -$2.09M
MDGL icon
113
Madrigal Pharmaceuticals
MDGL
$11.9B
$767K ﹤0.01%
3,319
-160,500
-98% -$43.5M
CYTK icon
114
Cytokinetics
CYTK
$10.7B
$710K ﹤0.01%
21,772
-916,300
-98% -$33.9M
EDU icon
115
New Oriental
EDU
$8.88B
$513K ﹤0.01%
13,000
– –
KRTX
116
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$477K ﹤0.01%
2,200
– –
LUNRW
117
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$462K ﹤0.01%
950,000
– –
BNTX icon
118
BioNTech
BNTX
$29.3B
$415K ﹤0.01%
3,844
-133,800
-97% -$15M
ALNY icon
119
Alnylam Pharmaceuticals
ALNY
$31.6B
$380K ﹤0.01%
2,000
-4,719
-70% -$936K
GRND.WS
120
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$378K ﹤0.01%
540,000
– –
BTTX
121
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$357K ﹤0.01%
330,619
-368,423
-53% -$356K
CLVR
122
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$330K ﹤0.01%
54,312
-9,953
-15% -$81.1K
ARWR icon
123
Arrowhead Research
ARWR
$12.3B
$207K ﹤0.01%
+5,800
New +$200K
IONS icon
124
Ionis Pharmaceuticals
IONS
$9.93B
$205K ﹤0.01%
+5,000
New +$192K
AAC.WS
125
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$160K ﹤0.01%
200,000
– –
3 4
5
6 7

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2023 Portfolio in Review

As of Q2 2023, Thomas Steyer held 208 positions worth $19.9B, up 8.8% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Thomas Steyer's Q2 2023 filing shows 17 new, 41 increased, 35 reduced and 35 closed positions. Its largest new stake was Analog Devices: 2,075,000 shares worth $404M. The largest sale was Shaw Communications Inc., an estimated $473M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Thomas Steyer's largest Q2 2023 buy was Analog Devices: 2,075,000 shares worth $404M.
  • Thomas Steyer added most to VMware, Inc in Q2 2023, an estimated $286M increase.
  • Thomas Steyer's biggest Q2 2023 reduction was Salesforce, cutting an estimated $318M.
  • Thomas Steyer fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $473M.
  • Thomas Steyer's ten largest holdings make up 44% of its $19.9B portfolio in Q2 2023.
  • Thomas Steyer opened 17 new positions and closed 35 in Q2 2023.
  • Thomas Steyer's portfolio value rose 8.8% quarter-over-quarter to $19.9B.

Based on Farallon Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.